Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk.
Cui Y, Shu XO, Li HL, Yang G, Wen W, Gao YT, Cai Q, Rothman N, Yin HY, Lan Q, Xiang YB, Zheng W.
Cui Y, et al. Among authors: yin hy.
Int J Cancer. 2017 Dec 15;141(12):2423-2429. doi: 10.1002/ijc.31007. Epub 2017 Aug 29.
Int J Cancer. 2017.
PMID: 28815606
Free PMC article.